Soleus Capital Management, L.P. Amylyx Pharmaceuticals, Inc. Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$20.98 - $31.42 $1.19 Million - $1.78 Million	56,786 Added 89.83%	120,000 $2.59 Million
Q1 2023 May 15, 2023	BUY	$27.71 - $40.93 $348,536 - $514,817	12,578 Added 24.84%	63,214 $1.85 Million
Q4 2022 Feb 14, 2023	SELL	$29.75 - $39.26 $11.3 Million - $14.9 Million	-378,700 Reduced 88.21%	50,636 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $7.36 Million - $13.3 Million	429,336 New	429,336 $12.1 Million

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $310M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.